- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Merck's Keytruda regimen granted FDA approval to treat endometrial cancer | ||
| Di | Roche announces positive phase 3 results for Columvi combination in DLBCL | ||
| Di | AstraZeneca's Calquence shows survival benefit in phase 3 mantle cell lymphoma study | ||
| Di | Takeda shares late-stage results for investigational soticlestat in rare epileptic disorders | ||
| Di | PM Society's charity partner announced as Acrodysostosis Support and Research | ||
| Di | Spotting creative opportunities is like spotting yellow cars | ||
| Mo | AstraZeneca's Imfinzi regimen granted FDA approval to treat endometrial cancer | ||
| Mo | Amgen's Blincyto approved by FDA for new acute lymphoblastic leukaemia indication | ||
| Mo | Janssen/Pharmacyclics' ibrutinib shows continued survival benefit in chronic lymphocytic leukaemia | ||
| Mo | Pfizer shares positive overall survival results for Elrexfio in multiple myeloma | ||
| Mo | Celltrion's RoActemra biosimilar shows promise in phase 3 rheumatoid arthritis study | ||
| Mo | Maximising the impact of creativity in healthcare | ||
| Fr | AbbVie gains rights to FutureGen's inflammatory bowel disease candidate in deal worth $1.7bn | ||
| Fr | Bristol Myers Squibb's Augtyro granted expanded FDA approval for solid tumours | ||
| Fr | Roche's spinal muscular atrophy treatment Evrysdi shows continued benefit in children | ||
| Fr | Pfizer/Flagship's drug discovery partnership to focus on obesity treatments | ||
| Fr | KCL research could speed up discovery of new antibiotics in fight against AMR | ||
| Fr | Innovation in oncology | ||
| Do | AstraZeneca's Farxiga granted FDA approval to treat type 2 diabetes in paediatric patients | ||
| Do | Roche enters licensing agreement with ALZpath to advance Alzheimer's blood test | ||
| Do | Eli Lilly's GIP/GLP-1 receptor agonist tirzepatide shows promise in fatty liver disease MASH | ||
| Do | GSK and Ochre Bio enter multi-year partnership to investigate liver disease drivers | ||
| Do | MIT protein study could help accelerate development of new antibiotics | ||
| 12.06. | Ipsen's Iqirvo receives FDA approval to treat adults with primary biliary cholangitis | ||
| 12.06. | J&J agrees $700m settlement with US states to resolve talcum powder claims |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
